Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 297.04 K | $885.17 K | 14.21% | 0.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 104.55 K | $311.64 K | 0.00% | 0.29% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2025 | 100.00 K | $298.00 K | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 44.68 K | $133.15 K | 0.00% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 41.30 K | $123.06 K | 6.17% | 0.11% |
| STATE STREET CORP | 11/14/2025 | 40.30 K | $120.09 K | 0.00% | 0.11% |
| SEACREST WEALTH MANAGEMENT, LLC | 11/13/2025 | 34.95 K | $112.55 K | 0.00% | 0.10% |
| GSB WEALTH MANAGEMENT, LLC | 10/21/2025 | 30.00 K | $89.40 K | 0.00% | 0.08% |
| BLACKROCK, INC. | 11/12/2025 | 26.67 K | $79.46 K | 2.89% | 0.07% |
| NORTHERN TRUST CORP | 11/14/2025 | 19.27 K | $57.43 K | 0.00% | 0.05% |
| CAPTRUST FINANCIAL ADVISORS | 11/19/2025 | 13.14 K | $39.16 K | 0.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 3.00 K | $8.94 K | 0.00% | 0.01% |
| MEASURED WEALTH PRIVATE CLIENT GROUP, LLC | 11/14/2025 | 1.00 K | $2.98 K | 100.00% | 0.00% |
| TRIFECTA CAPITAL ADVISORS, LLC | 11/03/2025 | 714 | $2.13 K | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 571 | $1.70 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 457 | $1.36 K | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 355 | $1.06 K | -79.18% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 10/07/2025 | 100 | $298 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 71 | $212 | 0.00% | 0.00% |
| TEAM FINANCIAL GROUP, LLC | 10/07/2025 | 71 | $212 | 0.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 44 | $131 | 4,300.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 24 | $72 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 7 | $21 | -93.20% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 6 | $18 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 3 | $9 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 2 | $6 | -98.17% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 1 | $1 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
Armata Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 297,038
GEODE CAPITAL MANAGEMENT, LLC: 104,546
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 44,682
RENAISSANCE TECHNOLOGIES LLC: 41,296
STATE STREET CORP: 40,300
2.10% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 781.29 K shares in the last 24 months. This purchase volume represents approximately $2.42 M in transactions.